155891-93-3 Usage
Description
(3,5-Dichloro-4-hydroxy-phenyl)-carbamic acid tert-butyl ester, also known as diuron, is a chemical compound that belongs to the class of urea herbicides. It is commonly used as an herbicide to control weeds in various agricultural and horticultural crops, as well as on non-crop land. Diuron works by inhibiting photosynthesis in plants, leading to their eventual death. It is considered to have moderate toxicity in humans and has been identified as a potential environmental contaminant due to its persistence in soil and water.
Uses
Used in Agricultural and Horticultural Industries:
(3,5-Dichloro-4-hydroxy-phenyl)-carbamic acid tert-butyl ester is used as a herbicide for controlling weeds in various agricultural and horticultural crops. It helps to protect the crops from being overtaken by weeds, ensuring better growth and yield.
Used in Non-Crop Land Management:
(3,5-Dichloro-4-hydroxy-phenyl)-carbamic acid tert-butyl ester is also used as a herbicide on non-crop land to control the growth of unwanted plants and maintain the land for various purposes, such as construction sites or recreational areas.
Regulated Use:
Due to its moderate toxicity in humans and potential environmental contamination, the use of (3,5-Dichloro-4-hydroxy-phenyl)-carbamic acid tert-butyl ester is regulated in many countries. This is done to minimize its ecological and health impact and ensure that it is used responsibly and safely.
Check Digit Verification of cas no
The CAS Registry Mumber 155891-93-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,8,9 and 1 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 155891-93:
(8*1)+(7*5)+(6*5)+(5*8)+(4*9)+(3*1)+(2*9)+(1*3)=173
173 % 10 = 3
So 155891-93-3 is a valid CAS Registry Number.
155891-93-3Relevant articles and documents
MODULATORS OF THR-β AND METHODS OF USE THEREOF
-
Paragraph 00680, (2020/11/23)
Disclosed herein are compounds of Formula (I) or a pharmaceutically acceptable salt, prodrug, amide or ester thereof, where i) TL is a moiety of Formula IlIa, lIIb, IlIa, IIIb, IIIc, or IIId; ii) CE is a moiety of Formula IV; iii) HD is a moiety of Formula V or VI; where the substituents are as defined herein. Disclosed are also pharmaceutical compositions comprising the above compounds, and methods of treating disease by administering or contact a patient with one or more of the above compounds.
PYRIDINE COMPOUNDS AND USES THEREOF
-
Page/Page column 24; 25, (2013/03/26)
The present invention is directed to pyridine compounds of Formula (I). Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds as therapeutic agents treating neurological and psych
IMIDAZOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
-
Page/Page column 115, (2011/10/10)
The invention provides compounds of Formulas Ia-Ib, stereoisomers or pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R4, R5 and R16 are defined herein, a pharmaceutical composition that includes a compound of Formulas Ia-Ib and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of using the compound or composition in therapy.
